Differentiating disease activity from damage in systemic sclerosis: it's still early days!

Ann Rheum Dis. 2020 Aug;79(8):e98. doi: 10.1136/annrheumdis-2019-215588. Epub 2019 May 22.

Authors

Siddharth Jain¹, Shefali Khanna Sharma²

Affiliations

¹ Clinical Immunology and Rheumatology, Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
² Clinical Immunology and Rheumatology, Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, Indiaa sharmashefali@hotmail.com.

PMID: 31118192
DOI: 10.1136/annrheumdis-2019-215588

No abstract available

Keywords: disease activity; outcomes research; systemic sclerosis.

Publication types

Letter
Comment

MeSH terms

Humans
Scleroderma, Localized*
Scleroderma, Systemic*